GGrantIndex
Sort

166,118 grants matching stem cells

MOUSE GENETICS

$963,853
Willie H Mark · Sloan-Kettering Inst Can Research · P30 · FY2011 · CA

Neurodegenerative mechanisms in Christianson syndrome and NHE6-related disorders

$963,816
Eric M Morrow · Brown University · R01 · FY2019 · NS

Genome Instability in Cancer Development

$963,810
Kyungjae Myung · National Human Genome Research Institute · ZIA · FY2012 · HG

Neural Control Of Gaze

$963,738
Lance M Optican · National Eye Institute · ZIA · FY2015 · EY

Respiratory Effects of Silver and Carbon Nanomaterials (RESAC)

$963,721
Junfeng Zhang · University Of Southern California · U19 · FY2011 · ES

2/3 Schizophrenia Genetics and Brain Somatic Mosaicism

$963,659
John V Moran · University Of Michigan At Ann Arbor · U01 · FY2017 · MH

Targeted Lymphoablation as an alternative to HSCT to cure T1D

$963,581
Theresa Deisher · Avm Biotechnology, Llc · R44 · FY2023 · DK

Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing

$963,541
Jabe L Curley · Axosim, Inc. · R42 · FY2017 · TR

Genetics Core

$963,527
Andrew J Saykin · Northern California Institute/Res/Edu · U19 · FY2022 · AG

Xenogeneic Stem Cell and Thymic Replacement in AIDS

$963,510
Massachusetts General Hospital · P01 · FY2004 · AI

MMRRC Informatics, Coordination, and Service Center at UC Davis

$963,407
Eric Kenneth Engelhard · University Of California At Davis · U42 · FY2012 · OD

Dental Stem Cells and Tooth Tissue Engineering

$963,363
Pamela C Yelick · Tufts University Boston · R01 · FY2011 · DE

Cellular In vivo Imaging

$963,353
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Reversing Cellular immortality in cancer

$962,915
Steven E Artandi · Stanford University · R35 · FY2020 · CA

Reversing Cellular immortality in cancer

$962,915
Steven E Artandi · Stanford University · R35 · FY2018 · CA

Reversing Cellular immortality in cancer

$962,884
Steven E Artandi · Stanford University · R35 · FY2017 · CA

2/3: The Chicago Cancer Health Equity Collaborative (ChicagoCHEC)

$962,867
Christina Ciecierski · Northeastern Illinois University · U54 · FY2022 · CA

Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics

$962,824
Leor S Weinberger · J. David Gladstone Institutes · R37 · FY2021 · AI

Safe and effective anti CD154 antibodies for therapeutic intervention

$962,696
Matthew F. Mackey · Immunext, Inc. · R44 · FY2014 · AI

Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive

$962,626
Arno W Tilles · Sentien Biotechnologies, Inc. · R44 · FY2016 · DK

Alveolar Tissuegenesis in Murine Acute Lung Injury

$962,612
William J. Martin · National Institute Of Environmental Health Sciences · ZIA · FY2009 · ES

Immunobiology and immunotherapy of leukemia

$962,497
Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Characterization and improvement of graft versus leukemia effects

$962,497
Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Development of platforms for beta cell-specific delivery and ligand discovery

$962,401
Amit Choudhary · Broad Institute, Inc. · U01 · FY2024 · DK

DCTD Human Toxicology and Pharmacology

$962,236
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA